gvtcx

P2 Genomic Sequencing Resilience Capacity to the Genomics Programme

Department of Health and Social Care (T&T) Published 20 Sept 2021 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£12,360,000
Statuscomplete
Category (CPV) 73111000
Deadline2 Sept 2021
Contract start3 Sept 2021
Contract end31 Mar 2022
Procedureselective
SME suitableNo
OCIDocds-b5fd17-d0011e6f-fdbc-4a91-9159-68eb83924073

Awards (2)

This procurement was awarded to 2 suppliers. Values shown are per-award; the notice total is £12,360,000.

SupplierValueDateStatus
Crown Laboratories Limited £12,360,000 2 Sept 2021 active
IMMENSA HEALTH CLINIC LTD £12,360,000 2 Sept 2021 active

description

P2 Genomic Sequencing Resilience Capacity is required to provide assurance to the Genomics Programme, to ensure efficient monitoring of variant spread, reinfections, evolution of new variants in the country and importation of variants through travel. This can also act as a resilience capacity over the winter preparation if required.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
20 Sept 2021 Award (award) · f0f5ef99-6145-4281-baf1-25578f30395d-469708
20 Sept 2021 Award (award) · caa586c6-faf8-4a3a-a60d-22165ddf58b4-469714

more from Department of Health and Social Care (T&T)

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.